Abstract
Overview
Introduction
An overview ofthe market for portable inhalers, looking at market
shares,usefulness as tools for franchise protection and -expansion. Patient-
and physician preferences are being analyzed as well as suitablility of
molecules and inhaler types.,
Scope
- Summary of the advantages and disadvantages of the main types of portable
inhaler devices
- Market overview highlighting CFC-free and CFC-containing devices and
devices delivering branded and generic molecules, based on 2007 IMS Sales Data
- Overview of portable inhaler devices in non-pulmonary diseases, including
inhaled insulin for the treatment of diabetes
- Assessment of opportunities to use portable inhaler devices as key factors
in a product' s commercial success throughout its lifecycle
Report Highlights
Although a direct link between the type of device and level of disease control
has never been proven, the latter is possibly indirectly influenced by the
respective device' s ease of use, its airflow resistance and the patient' s
device preferences.
There are still opportunities in the asthma/COPD market to gain market share
by differentiating with an improved inhaler device. One of such strategies
would be to introduce a product line of different molecules in the same device
model in order to give physicians the opportunity to minimize the scope for
error on the patient side.
Inhaled drugs are increasingly being developed for systemic use in
non-pulmonary diseases. Reasons for this include improved patient acceptance
and compliance and a faster onset of action. However, the commercial failure
of Pfizer' s inhaled insulin illustrates the difficulties in striking the right
balance.
Reasons to Purchase
- Understand key advantages and disadvantages of different types of portable
inhaler devices
- Identify future challenges for portable inhaler devices and best method of
meeting these
- Assess the respiratory market' s segmentation and dynamics by device type
and brand/generic split
| 
View Cart
